Have a personal or library account? Click to login
Changes in synovial fluid biomarkers after experimental equine osteoarthritis Cover

Changes in synovial fluid biomarkers after experimental equine osteoarthritis

Open Access
|Dec 2017

References

  1. 1. Alwan W.H., Carter S.D., Bennett D., Edwards G.B.: Glycosaminoglycans in horses with osteoarthritis. Equine Vet J 1991, 23, 44–47.10.1111/j.2042-3306.1991.tb02712.x1901787
  2. 2. Bai B., Li Y.: Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity. J Orthopaedic Surg Res 2016, 11, 149.10.1186/s13018-016-0483-x512043627876074
  3. 3. Barrachina L., Remacha A.R., Soler L., García N., Romero A., Vázquez F.J., Vitoria A., Álava M.Á., Lamprave F., Rodellar C.: Acute phase protein haptoglobin as inflammatory marker in serum and synovial fluid in an equine model of arthritis. Vet Immunol Immunopathol 2016, 182, 74–78.10.1016/j.vetimm.2016.10.00527863554
  4. 4. Clegg P.D., Coughlan A.R., Riggs C.M., Carter S.D.: Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Vet J 1997, 29, 343–348.10.1111/j.2042-3306.1997.tb03137.x9306059
  5. 5. de Bakker E., Stroobants V., VanDael F., Ryssen B.V., Meyer E.: Canine synovial fluid biomarkers for early detection and monitoring of osteoarthritis. Vet Rec 2017, 180, 328–329.10.1136/vr.10398228364073
  6. 6. de Grauw J.C., van de Lest C.H.A., van Weeren P.R.: Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009, 11, R35.10.1186/ar2640268818019272138
  7. 7. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W.: Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008, 16, 1196–1204.10.1016/j.joca.2008.03.00818442931
  8. 8. Fuller C., Barr A.R., Sharif M., Dieppe P.: Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001, 9, 49–55.10.1053/joca.2000.034911178947
  9. 9. Garner B., Stoker A., Kuroki K., Evans R., Cook C.R., Cook J.: Using animal models in osteoarthritis biomarker research. J Knee Surg 2001, 24, 251–264.10.1055/s-0031-129736122303754
  10. 10. Gaudin P., Razakaboay M., Surla A., Berthier S., Fauconnier J., Morel F., Phelip X.: A study of metalloproteinases in fifty joint fluid specimens. Rev Rhumat 1997, 64, 375–381.
  11. 11. Gendron C., Kashiwagi M., Lim N.H., Enghild J.J., Thøgersen I.B., Hughes C., Caterson B., Nagase H.: Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 2007, 282, 18294–18306.10.1074/jbc.M70152320017430884
  12. 12. Heinegård D., Saxne T.: The role of the cartilage matrix in osteoarthritis. Nature Rev Rheumatol 2001, 7, 50–56.10.1038/nrrheum.2010.19821119607
  13. 13. Iwai K.: Diverse ubiquitin signaling in NF-κB activation. Trends Cell Biol 2012, 22, 355–364.10.1016/j.tcb.2012.04.00122543051
  14. 14. Jouglin M., Robert C., Valette J.P., Gavard F., Quintin-Colonna F., Denoix J.M.: Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Vet Res 2000, 31, 507–515.10.1051/vetres:2000136
  15. 15. Kamarainen O.P., Solovieva S., Vehmas T., Luoma K., Riihimaki H., Ala-Kokko L., Mannikko M., Leino-Arjas P.: Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 2008, 10, R21.10.1186/ar2374237445818257935
  16. 16. Kamm J.L., Nixon A.J., Witte T.H.: Cytokine and catabolic enzyme expression in synovium, synovial fluid, and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J 2010, 42, 693–699.10.1111/j.2042-3306.2010.00140.x418375521039798
  17. 17. Kapoor M., Martelpelletier J., Lajeunesse D., Pelletier J.P., Fahmi H.: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Prog Modern Biomed 2014, 7, 33–42.10.1038/nrrheum.2010.19621119608
  18. 18. Kozaci L.D., Buttle D.J., Hollander A.P.: Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheumatol 1997, 40, 164–174.10.1002/art.17804001219008612
  19. 19. Maldonado M., Nam J.: The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013, 2013, 284873.10.1155/2013/284873377124624069595
  20. 20. Marttinen P.H., Raulo S.M., Suominen M.M., Tulamo R.M.: Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac. J Vet Med 2006, 53, 311–318.10.1111/j.1439-0442.2006.00837.x16901276
  21. 21. Mokbel A.N., El Tookhy O.S., Shamaa A.A., Rashed L.A., Sabry D., El Sayed A.M.: Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011, 12, 259.10.1186/1471-2474-12-259323243822085445
  22. 22. Sawaji Y., Hynes J., Vincent T., Saklatvala J.: Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008, 58, 3498–3509.10.1002/art.2402518975307
  23. 23. Skioldebrand E., Ekman S., Mattsson Hulten L., Svala E., Bjorkman K., Lindahl A., Lundqvist A., Onnerfjord P., Sihlbom C., Ruetschi U.: Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis. Equine Vet J 2017, 49, 662–667.10.1111/evj.12666557394628097685
  24. 24. Skioldebrand E., Heinegard D., Eloranta M.L., Nilsson G., Dudhia J., Sandgren B., Ekman S.: Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds. J Orthop Res 2005, 23, 156–163.10.1016/j.orthres.2004.05.01315607888
  25. 25. Trumble T.N., Trotter G.W., Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., Billinghurst R.C., Frisbie D.D.: Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62, 1467–1477.10.2460/ajvr.2001.62.146711560279
  26. 26. Boom R., Brama P.A., Geesje H., Kiers G.H., Groot K.J., Weeren P.R.: Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses. Am J Vet Res 2004, 65, 296–302.10.2460/ajvr.2004.65.29615027675
  27. 27. Verma P., Dalal K.: ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011, 112, 3507–3514.10.1002/jcb.2329821815191
  28. 28. Wang G., Li X., Jiang R., Li Y., Fan X., Zheng Y., Gao L.: Changes in synovial fluid inflammatory mediators and cartilage biomarkers after experimental acute equine synovitis. Bull Vet Inst Pulawy 2015, 59, 129–131.10.1515/bvip-2015-0019
  29. 29. Zheng W., Zhang H., Jin Y., Wang Q., Chen L., Feng Z., Chen H., Wu Y.: Butein inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice. Int Immunopharmacol 2017, 42, 1–10.10.1016/j.intimp.2016.11.00927863298
Language: English
Page range: 503 - 508
Submitted on: Jul 5, 2017
|
Accepted on: Nov 9, 2017
|
Published on: Dec 27, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Tian-wen Ma, Yue Li, Guan-ying Wang, Xin-ran Li, Ren-li Jiang, Xiao-peng Song, Zhi-heng Zhang, Hui Bai, Xin Li, Li Gao, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.